Featuring slide presentations and related discussion from Dr Suresh S Ramalingam and Dr Helena Yu. Published April 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1.25 credits
MOC types
ABS — Accredited CMEUp to 1.25 pointsABIM — Medical KnowledgeUp to 1.25 pointsABS — Self-AssessmentUp to 1.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
-
ReleasedApr 27, 2026
-
Last day to claim creditApr 29, 2027 7 months left
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant NSCLC | 2026 (Webinar Video Proceedings)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for NSCLC | 2026 (Faculty Presentations)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Small Cell Lung Cancer | 2026 (Webinar Video Proceedings)
-
Clinical Care Options, LLC (dba Decera Clinical Education) Year in Review in EGFR-Mutated NSCLC: Impact of Recent Advances Across the Disease Continuum
-
Physicians’ Education Resource Show Me the Data: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC
-
Haymarket Medical Education What’s New? Updates on EGFR-directed Therapy in NSCLC
